Blunt traumatic injury to the thoracic aorta treated with thoracic endovascular aortic repair: a single-centre 20-year experience.


Journal

Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 06 04 2018
accepted: 03 06 2018
pubmed: 15 7 2018
medline: 30 7 2019
entrez: 15 7 2018
Statut: ppublish

Résumé

Blunt thoracic aortic injury can be treated with thoracic endovascular aortic repair (TEVAR) with excellent short and mid-term outcomes. However, few data are available about the long-term results. Our goal was to report our single-centre, 20-year experience using TEVAR to treat blunt thoracic aortic injury. We retrospectively reviewed our institutional database to identify all patients treated with TEVAR for traumatic lesions of the aortic isthmus. We identified 35 patients since 1998. Patients' charts were analysed for preoperative characteristics, intraoperative variables and short-term outcomes. Information about the long-term follow-up was collected by analysing cross-sectional images and via phone calls. Follow-up was 100% complete. Rates of survival and of freedom from aortic redo were estimated using Kaplan-Meier methods. Twenty-nine patients were men (82%). The median age was 42 years (range 22-79 years) and the mean injury severity score was 38 (±13). The endovascular procedure was successfully carried out in all patients. The left subclavian artery was intentionally overstented in 11 patients (31%). Two patients died perioperatively (5.7%). The estimated survival was 92% and 87% at 5 and 10 years, respectively, with no aorta-related deaths. The estimated freedom from aortic redo was 96% and 91% at 5 and 10 years, respectively. Our data corroborate the excellent results of the endovascular treatment of blunt thoracic aortic injury when follow-up is extended to 20 years. New-generation devices, which are more comfortable and have smaller diameters, may further improve the results of TEVAR in treating traumatic aortic injury. Surveillance with cross-sectional imaging remains mandatory.

Identifiants

pubmed: 30007311
pii: 5051699
doi: 10.1093/icvts/ivy211
doi:

Types de publication

Journal Article

Langues

eng

Pagination

17-22

Auteurs

Andrea Agostinelli (A)

Department of Cardiac Surgery, Parma University Hospital, Parma, Italy.

Davide Carino (D)

Department of Cardiac Surgery, Parma University Hospital, Parma, Italy.
Aortic Institute at Yale-New Haven, Yale University School of Medicine, New Haven, CT, USA.

Bruno Borrello (B)

Department of Cardiac Surgery, Parma University Hospital, Parma, Italy.

Carla Marcato (C)

Department of Radiology, Parma University Hospital, Parma, Italy.

Annalisa Volpi (A)

1st Anesthesia and Intensive Care Department, Parma University Hospital, Parma, Italy.

Tiziano Gherli (T)

Department of Cardiac Surgery, Parma University Hospital, Parma, Italy.

Francesco Nicolini (F)

Department of Cardiac Surgery, Parma University Hospital, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH